1-3 of 3
Richard D. Gelber
Close
Sort by
Journal Articles

Results of the Dana-Farber Cancer Institute ALL Consortium Protocol 95-01 for children with acute lymphoblastic leukemia

Clinical Trials & Observations
Albert Moghrabi, Donna E. Levy, Barbara Asselin, Ronald Barr, Luis Clavell, Craig Hurwitz, Yvan Samson, Marshall Schorin, Virginia K. Dalton, Steven E. Lipshultz, Donna S. Neuberg, Richard D. Gelber, Harvey J. Cohen, Stephen E. Sallan, Lewis B. Silverman
Journal: Blood
Blood (2006) 109 (3): 896–904.
https://doi.org/10.1182/blood-2006-06-027714
Published: 2006
Journal Articles

Outcome of Dana-Farber Cancer Institute (DFCI) Consortium Protocol 95–01 for Children with Newly Diagnosed Acute Lymphoblastic Leukemia (ALL).

Lewis B. Silverman, MD, Donna E. Levy, MS, Virginia K. Dalton, MS, PNP, Steven E. Lipshultz, MD, Richard D. Gelber, PhD, Stephen E. Sallan, MD
Journal: Blood
Blood (2004) 104 (11): 679.
https://doi.org/10.1182/blood.V104.11.679.679
Published: 2004
Journal Articles

Improved outcome for children with acute lymphoblastic leukemia: results of Dana-Farber Consortium Protocol 91-01

Clinical Trials & Observations
Lewis B. Silverman, Richard D. Gelber, Virginia Kimball Dalton, Barbara L. Asselin, Ronald D. Barr, Luis A. Clavell, Craig A. Hurwitz, Albert Moghrabi, Yvan Samson, Marshall A. Schorin, Steven Arkin, Lieven Declerck, Harvey J. Cohen, Stephen E. Sallan
Journal: Blood
Blood (2001) 97 (5): 1211–1218.
https://doi.org/10.1182/blood.V97.5.1211
Published: 2001